218 related articles for article (PubMed ID: 33140857)
21. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
22. Reduced expression of the RNA-binding protein HuD in pancreatic neuroendocrine tumors correlates with low p27
Kim C; Jeong DE; Heo S; Ji E; Rho JG; Jung M; Ahn S; Kim YJ; Kim YS; Nam SW; Kulkarni RN; Lee KB; Lee EK; Kim W
J Pathol; 2018 Oct; 246(2):231-243. PubMed ID: 30014466
[TBL] [Abstract][Full Text] [Related]
23. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia.
Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308
[TBL] [Abstract][Full Text] [Related]
24. Somatic alterations of CDKN1B are associated with small bowel neuroendocrine tumors.
Maxwell JE; Sherman SK; Li G; Choi AB; Bellizzi AM; O'Dorisio TM; Howe JR
Cancer Genet; 2015 Sep; ():. PubMed ID: 26603463
[TBL] [Abstract][Full Text] [Related]
25. p27
Podmirseg SR; Vosper J; Hengst L
J Pathol; 2019 May; 248(1):3-5. PubMed ID: 30549261
[TBL] [Abstract][Full Text] [Related]
26. Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours.
Samsom KG; Levy S; van Veenendaal LM; Roepman P; Kodach LL; Steeghs N; Valk GD; Wouter Dercksen M; Kuhlmann KFD; Verbeek WHM; Meijer GA; Tesselaar MET; van den Berg JG
Histopathology; 2021 Mar; 78(4):556-566. PubMed ID: 32931025
[TBL] [Abstract][Full Text] [Related]
27. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
28. Analysis of cyclin-dependent kinase inhibitor 1B mutation in Han Chinese women with premature ovarian failure.
Wang B; Ni F; Li L; Wei Z; Zhu X; Wang J; Cao Y; Ma X
Reprod Biomed Online; 2010 Aug; 21(2):212-4. PubMed ID: 20615757
[TBL] [Abstract][Full Text] [Related]
29. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
Wyatt AW; Annala M; Aggarwal R; Beja K; Feng F; Youngren J; Foye A; Lloyd P; Nykter M; Beer TM; Alumkal JJ; Thomas GV; Reiter RE; Rettig MB; Evans CP; Gao AC; Chi KN; Small EJ; Gleave ME
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29206995
[TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic p27
Calvayrac O; Nowosad A; Cabantous S; Lin LP; Figarol S; Jeannot P; Serres MP; Callot C; Perchey RT; Creff J; Taranchon-Clermont E; Rouquette I; Favre G; Pradines A; Manenti S; Mazieres J; Lee H; Besson A
J Pathol; 2019 Jan; 247(1):60-71. PubMed ID: 30206932
[TBL] [Abstract][Full Text] [Related]
31. The V109G polymorphism of the p27 gene CDKN1B indicates a worse outcome in node-negative breast cancer patients.
Schöndorf T; Eisele L; Göhring UJ; Valter MM; Warm M; Mallmann P; Becker M; Fechteler R; Weisshaar MP; Hoopmann M
Tumour Biol; 2004; 25(5-6):306-12. PubMed ID: 15627896
[TBL] [Abstract][Full Text] [Related]
32. Recurrent CDKN1B (p27) mutations in hairy cell leukemia.
Dietrich S; Hüllein J; Lee SC; Hutter B; Gonzalez D; Jayne S; Dyer MJ; Oleś M; Else M; Liu X; Słabicki M; Wu B; Troussard X; Dürig J; Andrulis M; Dearden C; von Kalle C; Granzow M; Jauch A; Fröhling S; Huber W; Meggendorfer M; Haferlach T; Ho AD; Richter D; Brors B; Glimm H; Matutes E; Abdel Wahab O; Zenz T
Blood; 2015 Aug; 126(8):1005-8. PubMed ID: 26065650
[TBL] [Abstract][Full Text] [Related]
33. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
[TBL] [Abstract][Full Text] [Related]
34. Multiomic sequencing of paired primary and metastatic small bowel carcinoids.
Postel MD; Darabi S; Howe JR; Liang WS; Craig DW; Demeure MJ
F1000Res; 2023; 12():417. PubMed ID: 37954063
[No Abstract] [Full Text] [Related]
35. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.
Chandramohan V; Mineva ND; Burke B; Jeay S; Wu M; Shen J; Yang W; Hann SR; Sonenshein GE
J Cell Biochem; 2008 Aug; 104(6):2091-106. PubMed ID: 18393360
[TBL] [Abstract][Full Text] [Related]
36. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
37. Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma.
Mirchandani D; Roses DF; Inghirami G; Zeleniuch-Jacquotte A; Cangiarella J; Guth A; Safyan RA; Formenti SC; Pagano M; Muggia F
Anticancer Res; 2011 Dec; 31(12):4401-5. PubMed ID: 22199306
[TBL] [Abstract][Full Text] [Related]
38. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.
Di Cristofano A; De Acetis M; Koff A; Cordon-Cardo C; Pandolfi PP
Nat Genet; 2001 Feb; 27(2):222-4. PubMed ID: 11175795
[TBL] [Abstract][Full Text] [Related]
39. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
40. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.
Simbolo M; Vicentini C; Mafficini A; Fassan M; Pedron S; Corbo V; Mastracci L; Rusev B; Pedrazzani C; Landoni L; Grillo F; Cingarlini S; Rindi G; Luchini C; Scarpa A; Lawlor RT
Virchows Arch; 2018 Dec; 473(6):709-717. PubMed ID: 30219970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
